Shopping Cart 0
Cart Subtotal
AED 0

Pen Needles Market: Current Analysis and Forecast (2021-2027)

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 14676

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 18713

Details

Pen needles are used with the pen injectors for the delivery of injectable dosage forms. A pen needle consists of a hollow needle that fits in a plastic hub and is further connected to the injection pen for drug delivery. Diabetes patients mainly use pen needles because they require multiple insulin injections per day. In comparison to the traditional syringes and vials, pen needles are more convenient and highly effective. The demand for Pen needles is increasing on account of the rising prevalence of Diabetes, Obesity, the rise in the geriatric population, high preference for pen needles over syringes and vials, rising awareness regarding minimally invasive procedures, and favorable reimbursement policies in selected countries. As per the Centers for Disease Control and Prevention (2020), there were 34.2 million people affected with diabetes (10.5% of the US population) in 2020, out of which 26.9 million people were diagnosed and 7.3 million people (21.4% are undiagnosed) were undiagnosed with Diabetes. However, some of the restraints in the market include poor healthcare reimbursement policies in developing and underdeveloped countries and needle anxiety.

Based on Type, the market is fragmented into Standard Pen Needles and Safety Pen Needles. The Standard Pen Needles segment holds the largest share in 2020 and the Safety Pen Needles sub-segment is expected to grow at lucrative during the forecasted period. The increasing awareness regarding the risks associated with blood-borne pathogen transmission, needle safety concerns amongst patients and doctors is intensifying the segment growth. As per the WHO report, at least 50% of injections in 14 of 19 countries were unsafe. Moreover, the association of unsafe injection practices leads to the transmission of bloodborne viruses such as hepatitis B and C, Ebola, Lassa virus infections, and malaria.

Based on Length, the market is fragmented into 4mm, 5mm, 6mm, 8mm, 10mm, and 12mm. The 8mm segment holds the largest share in 2020 and is expected to register the highest CAGR in the upcoming period owing to the high adoption of these needles among diabetes patients.

Based on Therapy, the market is fragmented into Glucagon-like Peptides, Insulin, and Growth Hormones. The Insulin segment holds the largest share in 2020 and is expected to register the highest CAGR in the upcoming period owing to the rising diabetic population. As per the IDF Diabetes Atlas Ninth edition 2019 report, approximately 463 million adults (20-79 years) were living with diabetes; by 2045 this will rise to 700 million.

Based on Mode of Purchase, the market is fragmented into Retail and Non-Retail. The Retail segment holds the largest share in 2020 and is expected to register the highest CAGR in the upcoming period owing to several discounts offered on retail purchases of pen needles, high convenience, rising awareness on pen needles, and the favorable reimbursement scenario in North America and Europe

For a better understanding of the market adoption of Pen Needles, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America will dominate the Pen Needles market on account of the increasing geriatric population coupled with the rising prevalence of diabetes diseases, and high healthcare spending, Some of the major players operating in the market include Allinson Medical, Inc., Artsana S.p.a, B. Braun Melsungen AG, Becton Dickinson and Company, HTL Strefa S.A., Novo Nordisk, Owen Mumford Ltd., Terumo Corporation, Ultimed Inc., and Ypsomed Holding AG. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.

READ MORE

Table Of Content

Scope

1 MARKET INTRODUCTION

1.1. Market Definitions

1.2. Objective of the Study

1.3. Limitation

1.4. Stake Holders

1.5. Currency Used in Report

1.6. Scope of the Global Pen Needles Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Methodology for the Global Pen Needles Market

2.1.1. Main Objective of the Global Pen Needles Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL PEN NEEDLES MARKET REVENUE (USD MN), 2019-2027F

6 MARKET INSIGHTS BY TYPE

6.1. Standard Pen Needles

6.2. Safety Pen Needles

7 MARKET INSIGHTS BY LENGTH

7.1. 4mm

7.2. 5mm

7.3. 6mm

7.4. 8mm

7.5. 10mm

7.6. 12mm

8 MARKET INSIGHTS BY THERAPY

8.1. Glucagon-like Peptides

8.2. Insulin

8.3. Growth Hormones

9 MARKET INSIGHTS BY MODE OF PURCHASE

9.1. Retail

9.2. Non-Retail

10 MARKET INSIGHTS BY REGION

10.1. North America Pen Needles Market

10.1.1. United States

10.1.2. Canada

10.1.3. Rest of North America

10.2. Europe Pen Needles Market

10.2.1. Germany

10.2.2. United Kingdom

10.2.3. France

10.2.4. Spain

10.2.5. Rest of Europe

10.3. Asia Pacific Pen Needles Market

10.3.1. China

10.3.2. Japan

10.3.3. India

10.3.4. Australia

10.3.5. Rest of Asia Pacific

10.4. Rest of the World Pen Needles Market

11 DEMAND AND SUPPLY SIDE ANALYSIS

11.1. Demand Side Analysis

11.2. Supply Side Analysis

11.2.1. Top Product Launches

11.2.2. Top Business Partnerships

11.2.3. Top Business Expansions, Investments and Divestitures

11.2.4. Top Merger and Acquisitions

12 VALUE CHAIN ANALYSIS

13 GLOBAL PEN NEEDLES MARKET TRENDS & INSIGHTS

14 GLOBAL PEN NEEDLES MARKET DYNAMICS

14.1. Market Drivers

14.2. Market Challenges

14.3. Impact Analysis

15 GLOBAL PEN NEEDLES MARKET OPPORTUNITIES

16 COMPETITIVE SCENARIO

16.1. Porter's Five Forces Analysis

16.1.1. Bargaining power of Supplier

16.1.2. Bargaining power of Buyer

16.1.3. Industry Rivalry

16.1.4. Availability of Substitute

16.1.5. Threat of new Entrants

16.2. Competitive Landscape

16.2.1. Company Shares, By Revenue

17 COMPANY PROFILED

17.1. Allinson Medical, Inc.

17.2. Artsana S.p.a

17.3. B. Braun Melsungen AG

17.4. Becton Dickinson and Company

17.5. HTL Strefa S.A.

17.6. Novo Nordisk

17.7. Owen Mumford Ltd.

17.8. Terumo Corporation

17.9. Ultimed Inc.

17.10. Ypsomed Holding AG

18 DISCLAIMER

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Allinson Medical

Inc.

Artsana S.p.a

B. Braun Melsungen AG

Becton Dickinson and Company

HTL Strefa S.A.

Novo Nordisk

Owen Mumford Ltd.

Terumo Corporation

Ultimed Inc.

and Ypsomed Holding AG

Company Profile

Company Profile Title

Pen needles are used with the pen injectors for the delivery of injectable dosage forms. A pen needle consists of a hollow needle that fits in a plastic hub and is further connected to the injection pen for drug delivery. Diabetes patients mainly use pen needles because they require multiple insulin injections per day. In comparison to the traditional syringes and vials, pen needles are more convenient and highly effective. The demand for Pen needles is increasing on account of the rising prevalence of Diabetes, Obesity, the rise in the geriatric population, high preference for pen needles over syringes and vials, rising awareness regarding minimally invasive procedures, and favorable reimbursement policies in selected countries. As per the Centers for Disease Control and Prevention (2020), there were 34.2 million people affected with diabetes (10.5% of the US population) in 2020, out of which 26.9 million people were diagnosed and 7.3 million people (21.4% are undiagnosed) were undiagnosed with Diabetes. However, some of the restraints in the market include poor healthcare reimbursement policies in developing and underdeveloped countries and needle anxiety.

Based on Type, the market is fragmented into Standard Pen Needles and Safety Pen Needles. The Standard Pen Needles segment holds the largest share in 2020 and the Safety Pen Needles sub-segment is expected to grow at lucrative during the forecasted period. The increasing awareness regarding the risks associated with blood-borne pathogen transmission, needle safety concerns amongst patients and doctors is intensifying the segment growth. As per the WHO report, at least 50% of injections in 14 of 19 countries were unsafe. Moreover, the association of unsafe injection practices leads to the transmission of bloodborne viruses such as hepatitis B and C, Ebola, Lassa virus infections, and malaria.

Based on Length, the market is fragmented into 4mm, 5mm, 6mm, 8mm, 10mm, and 12mm. The 8mm segment holds the largest share in 2020 and is expected to register the highest CAGR in the upcoming period owing to the high adoption of these needles among diabetes patients.

Based on Therapy, the market is fragmented into Glucagon-like Peptides, Insulin, and Growth Hormones. The Insulin segment holds the largest share in 2020 and is expected to register the highest CAGR in the upcoming period owing to the rising diabetic population. As per the IDF Diabetes Atlas Ninth edition 2019 report, approximately 463 million adults (20-79 years) were living with diabetes; by 2045 this will rise to 700 million.

Based on Mode of Purchase, the market is fragmented into Retail and Non-Retail. The Retail segment holds the largest share in 2020 and is expected to register the highest CAGR in the upcoming period owing to several discounts offered on retail purchases of pen needles, high convenience, rising awareness on pen needles, and the favorable reimbursement scenario in North America and Europe

For a better understanding of the market adoption of Pen Needles, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America will dominate the Pen Needles market on account of the increasing geriatric population coupled with the rising prevalence of diabetes diseases, and high healthcare spending, Some of the major players operating in the market include Allinson Medical, Inc., Artsana S.p.a, B. Braun Melsungen AG, Becton Dickinson and Company, HTL Strefa S.A., Novo Nordisk, Owen Mumford Ltd., Terumo Corporation, Ultimed Inc., and Ypsomed Holding AG. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.

READ MORE

Scope

1 MARKET INTRODUCTION

1.1. Market Definitions

1.2. Objective of the Study

1.3. Limitation

1.4. Stake Holders

1.5. Currency Used in Report

1.6. Scope of the Global Pen Needles Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Methodology for the Global Pen Needles Market

2.1.1. Main Objective of the Global Pen Needles Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL PEN NEEDLES MARKET REVENUE (USD MN), 2019-2027F

6 MARKET INSIGHTS BY TYPE

6.1. Standard Pen Needles

6.2. Safety Pen Needles

7 MARKET INSIGHTS BY LENGTH

7.1. 4mm

7.2. 5mm

7.3. 6mm

7.4. 8mm

7.5. 10mm

7.6. 12mm

8 MARKET INSIGHTS BY THERAPY

8.1. Glucagon-like Peptides

8.2. Insulin

8.3. Growth Hormones

9 MARKET INSIGHTS BY MODE OF PURCHASE

9.1. Retail

9.2. Non-Retail

10 MARKET INSIGHTS BY REGION

10.1. North America Pen Needles Market

10.1.1. United States

10.1.2. Canada

10.1.3. Rest of North America

10.2. Europe Pen Needles Market

10.2.1. Germany

10.2.2. United Kingdom

10.2.3. France

10.2.4. Spain

10.2.5. Rest of Europe

10.3. Asia Pacific Pen Needles Market

10.3.1. China

10.3.2. Japan

10.3.3. India

10.3.4. Australia

10.3.5. Rest of Asia Pacific

10.4. Rest of the World Pen Needles Market

11 DEMAND AND SUPPLY SIDE ANALYSIS

11.1. Demand Side Analysis

11.2. Supply Side Analysis

11.2.1. Top Product Launches

11.2.2. Top Business Partnerships

11.2.3. Top Business Expansions, Investments and Divestitures

11.2.4. Top Merger and Acquisitions

12 VALUE CHAIN ANALYSIS

13 GLOBAL PEN NEEDLES MARKET TRENDS & INSIGHTS

14 GLOBAL PEN NEEDLES MARKET DYNAMICS

14.1. Market Drivers

14.2. Market Challenges

14.3. Impact Analysis

15 GLOBAL PEN NEEDLES MARKET OPPORTUNITIES

16 COMPETITIVE SCENARIO

16.1. Porter's Five Forces Analysis

16.1.1. Bargaining power of Supplier

16.1.2. Bargaining power of Buyer

16.1.3. Industry Rivalry

16.1.4. Availability of Substitute

16.1.5. Threat of new Entrants

16.2. Competitive Landscape

16.2.1. Company Shares, By Revenue

17 COMPANY PROFILED

17.1. Allinson Medical, Inc.

17.2. Artsana S.p.a

17.3. B. Braun Melsungen AG

17.4. Becton Dickinson and Company

17.5. HTL Strefa S.A.

17.6. Novo Nordisk

17.7. Owen Mumford Ltd.

17.8. Terumo Corporation

17.9. Ultimed Inc.

17.10. Ypsomed Holding AG

18 DISCLAIMER

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Allinson Medical

Inc.

Artsana S.p.a

B. Braun Melsungen AG

Becton Dickinson and Company

HTL Strefa S.A.

Novo Nordisk

Owen Mumford Ltd.

Terumo Corporation

Ultimed Inc.

and Ypsomed Holding AG